Lateef Investment Management L.P. purchased a new position in Iqvia Holdings Inc (NYSE:IQV) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 443,114 shares of the medical research company’s stock, valued at approximately $43,381,000. Iqvia makes up 4.1% of Lateef Investment Management L.P.’s portfolio, making the stock its 7th biggest holding. Lateef Investment Management L.P. owned about 0.21% of Iqvia as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also modified their holdings of the stock. Raymond James & Associates bought a new position in shares of Iqvia in the 4th quarter worth about $14,754,000. Bain Capital Public Equity Management LLC bought a new position in shares of Iqvia in the 4th quarter worth about $32,525,000. Teachers Retirement System of The State of Kentucky bought a new position in shares of Iqvia in the 4th quarter worth about $19,864,000. California State Teachers Retirement System bought a new position in shares of Iqvia in the 4th quarter worth about $26,010,000. Finally, Two Sigma Investments LP bought a new position in shares of Iqvia in the 4th quarter worth about $12,062,000. Institutional investors own 92.34% of the company’s stock.
Shares of Iqvia Holdings Inc (IQV) opened at $105.60 on Monday. Iqvia Holdings Inc has a 1 year low of $76.80 and a 1 year high of $110.67. The company has a market cap of $21,993.32, a PE ratio of 22.91, a P/E/G ratio of 2.70 and a beta of 0.64. The company has a debt-to-equity ratio of 1.21, a quick ratio of 1.19 and a current ratio of 1.19.
Several research analysts recently issued reports on IQV shares. Zacks Investment Research upgraded shares of Iqvia from a “hold” rating to a “buy” rating and set a $112.00 price target for the company in a research note on Thursday, January 18th. SunTrust Banks upgraded shares of Iqvia from a “hold” rating to a “buy” rating in a research note on Wednesday, March 7th. Evercore ISI initiated coverage on shares of Iqvia in a research note on Thursday, January 18th. They issued an “outperform” rating and a $112.00 price target for the company. Mitsubishi UFJ Financial Group initiated coverage on shares of Iqvia in a research report on Friday, December 15th. They set a “neutral” rating and a $112.00 price objective on the stock. Finally, TheStreet raised shares of Iqvia from a “c+” rating to a “b” rating in a research report on Wednesday, December 13th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $110.02.
In other news, Director Michael J. Evanisko sold 816 shares of the firm’s stock in a transaction dated Monday, March 5th. The shares were sold at an average price of $100.00, for a total transaction of $81,600.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider James H. Erlinger III sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, January 17th. The shares were sold at an average price of $99.97, for a total transaction of $999,700.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 30,816 shares of company stock worth $3,093,400. Insiders own 6.00% of the company’s stock.
TRADEMARK VIOLATION WARNING: “443,114 Shares in Iqvia Holdings Inc (IQV) Acquired by Lateef Investment Management L.P.” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at https://www.americanbankingnews.com/2018/03/12/443114-shares-in-iqvia-holdings-inc-iqv-acquired-by-lateef-investment-management-l-p.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.